Sterling Capital Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$341K Buy
15,036
+793
+6% +$18.2K 0.01% 979
2026
Q1
$332K Sell
14,243
-7,867
-36% -$169K 0.01% 941
2025
Q4
$442K Buy
22,110
+146
+0.7% +$2.85K 0.01% 998
2025
Q3
$401K Buy
21,964
+323
+1% +$6.3K 0.01% 1059
2025
Q2
$435K Sell
21,641
-536
-2% -$10.3K 0.01% 982
2025
Q1
$402K Sell
22,177
-747
-3% -$13.4K 0.01% 950
2024
Q4
$398K Buy
22,924
+1,452
+7% +$27.9K 0.01% 1046
2024
Q3
$415K Buy
+21,472
New +$396K 0.01% 958
2019
Q3
$792K Buy
75,101
+22,417
+43% +$268K 0.01% 703
2019
Q2
$767K Hold
52,684
0.01% 684
2019
Q1
$739K Buy
52,684
+23,366
+80% +$378K 0.01% 688
2018
Q4
$512K Hold
29,318
0.01% 739
2018
Q3
$447K Buy
29,318
+89
+0.3% +$1.28K ﹤0.01% 795
2018
Q2
$403K Sell
29,229
-29,913
-51% -$448K ﹤0.01% 774
2018
Q1
$986K Buy
59,142
+382
+0.7% +$5.9K 0.01% 621
2017
Q4
$834K Buy
+58,760
New +$784K 0.01% 685

Other funds holding INVA

Sterling Capital Management's INVA Position: Q2 2026 in Review

Sterling Capital Management increased its Innoviva (INVA) stake by 5.6% in Q2 2026, buying an estimated $18.2K and bringing the position to 15,036 shares worth $341K. The position accounts for 0.01% of the portfolio, ranked #979.

Sterling Capital Management first reported a position in INVA in Q4 2017 and has held it in 16 quarters since. The position peaked at $986K in Q1 2018. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Sterling Capital Management held 15,036 shares of Innoviva worth $341K as of Q2 2026.
  • Sterling Capital Management bought 793 Innoviva shares in Q2 2026, an estimated $18.2K.
  • Innoviva made up 0.01% of Sterling Capital Management's portfolio in Q2 2026, its #979 holding.
  • Sterling Capital Management first reported a position in Innoviva in Q4 2017 and has held it in 16 quarters since.
  • Sterling Capital Management's Innoviva position peaked at $986K in Q1 2018.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.